Zofran® Lawyer

Hiring a Zofran lawyer with extensive experience litigating birth defect cases against drug manufacturers gives Zofran clients confidence they are hiring qualified counsel to represent them. You will be better served by choosing a Zofran lawyer with many years’ experience handling drug-induced birth defect cases and a long record of success.

Baum, Hedlund, Aristei & Goldman represents clients across the United States in Zofran birth defect cases. The firm has been a formidable legal force taking on major pharmaceutical companies such as GlaxoSmithKline (GSK), the maker of Zofran, as well as Bayer, Eli Lilly, Forest Labs, Pfizer, Wyeth and many others. The firm has recovered over $1.4 billion for their past clients in all areas of our practice. 1

In particular, Baum, Hedlund, Aristei & Goldman has litigated drug-induced birth defects against drug companies for years during which time we handled over 1,300 such cases, including “off label” cases where drug companies have encouraged doctors to prescribe their drugs for uses not approved by the FDA.

Our Zofran lawyer team has an in-depth understanding of biomedical re­search, clinical trials, statistics, the pharmaceutical industry and marketing, as well as effective discovery procedures and sophisticated work with experts on complicated scientific issues.

Baum Hedlund’s Track Record against GSK

Our firm has pursued personal injury, wrongful death and consumer class action cases against GSK for over 15 years. In fact, we have filed more than 3,500 individual cases against GSK involving Paxil personal injury and wrongful death, Paxil pediatric class actions, Avandia heart attacks, and now handle Zofran birth defect cases.

Over the course of litigating cases against GSK, our firm has collected hundreds of thousands of pages of internal GSK documents and conducted dozens of depositions of GSK executives, employees, physicians, researchers and academics. As a result, our firm knows how GSK operates, knows its tactics, the players, and how to get the evidence needed to effectively prosecute cases against GSK.

While representing our clients, a Baum Hedlund Zofran lawyer will dig deep into pharmaceutical company files to discover the truth about what the company knew about the drug’s risks, when the company knew of those risks and what efforts, if any, the company took to hide those risks. Only through legal action can anyone gain access to this type of information, as acknowledged in a Wall Street Journal article written about our firm on June 20, 2008, U.S. Probe of Glaxo’s Paxil Widens.

For example, our firm uncovered a sophisticated ghostwriting program, known as CASPPER, which GSK used to promote its antidepressant Paxil, allowing doctors to take credit for medical journal articles mainly written by GSK consultants. According to the CASPPER memo, which dates from April 2000, the program was designed to “strengthen the product positioning and overcome competitive issues.”

Our firm goes beyond the courtroom to advocate for safer products. We have delivered presentations before the FDA at public meetings on four separate occasions. We, together with our clients, have testified about the need for better warnings on antidepressants and the injuries they can cause. Our efforts, alongside many others, helped bring about the black box suicidality warning for children and young adults, now on most antidepressant labels. Most recently, one of our lawyers gave a presentation to the FDA in support of holding generic drug companies just as responsible for their drug warning labels as that of the brand manufacturers, thus allowing generic drug manufacturers to be held accountable by consumers when they fail to properly warn about the dangers of their drugs.

We have also assisted Congressional Investigators from two separate Committee investigations looking into the antidepressant safety. Two Congressional hearings were later held at which pharmaceutical executives and FDA officials were interrogated about their failure to protect the public health related to antidepressants and their association with suicidality.

Rigorously investigating devastating drug injuries requires relentless focus and dedication to our clients’ causes. We are tenacious when it comes to seeking evidence and have routinely prevailed in both state and federal courts.

Many of our attorneys have been honored with Client Distinction Awards based on client review ratings issued by Lawyers.com and Martindale-Hubbell for Quality of Service, Responsiveness, Communication Ability and Value. The firm has Martindale Hubbell’s highest AV® Preeminent™ Peer Review Rating, and is also listed in Martindale Hubbell’s Bar Register of Preeminent Lawyers, The Best Lawyers in America®, 2014 and 2015 Top Ranked Law Firms™  2 Additionally, five of our attorneys are listed in the Nation’s Top One Percent, National Association of Distinguished Counsel.

If you would like to seek compensation in your Zofran birth defect case, please call a Zofran lawyer at Baum, Hedlund, Aristei and Goldman at 1-800-827-0087 or complete our Zofran intake form.

1. Our past performance, verdicts or settlements do not constitute a guarantee, warranty, or prediction regarding the outcome of your legal matter.  Past results obtained or overall performance must be confined to that particular case, its factual and legal circumstances and legal surroundings.  Every case is different and must be judged on its own merits.

2. “AV® Preeminent™ is certification mark of Reed Elsevier Properties Inc., used in accordance with the Martindale-Hubbell certification procedures, standards and policies.”  “An AV® rating reflects an attorney who has reached the heights of professional excellence.  He or she has usually practiced law for many years, and is recognized for the highest levels of skill and integrity.”  Best Lawyers and The Best Lawyers in America are registered trademarks of Woodward/White, Inc., of Aiken, SC.